Polypharmacology: Principles and Methodologies
Autor Zhiguo Wang, Baofeng Yangen Limba Engleză Hardback – 2 aug 2022
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 1076.75 lei 38-44 zile | |
Springer International Publishing – 3 aug 2023 | 1076.75 lei 38-44 zile | |
Hardback (1) | 1113.12 lei 22-36 zile | |
Springer International Publishing – 2 aug 2022 | 1113.12 lei 22-36 zile |
Preț: 1113.12 lei
Preț vechi: 1171.70 lei
-5% Nou
Puncte Express: 1670
Preț estimativ în valută:
213.02€ • 225.28$ • 177.69£
213.02€ • 225.28$ • 177.69£
Carte disponibilă
Livrare economică 09-23 decembrie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783031049972
ISBN-10: 3031049977
Pagini: 856
Ilustrații: XXV, 856 p. 12 illus., 9 illus. in color. In 2 volumes, not available separately.
Dimensiuni: 178 x 254 mm
Greutate: 1.97 kg
Ediția:2022
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
ISBN-10: 3031049977
Pagini: 856
Ilustrații: XXV, 856 p. 12 illus., 9 illus. in color. In 2 volumes, not available separately.
Dimensiuni: 178 x 254 mm
Greutate: 1.97 kg
Ediția:2022
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland
Cuprins
PART I. Polypharmacology as a New Branch of Pharmacology: Concept and Principles.- Basics of Polypharmacology.- Polypharmacology in Clinical Applications: Multitarget Multidrug-combination (MTMD-C).- Polypharmacology in Clinical Applications: Multitarget Multidrug-single-formulation (MTMD-SF).- Polypharmacology in Clinical Applications: Multitarget Single-drug (MTSD).- Polypharmacology in Drug Discovery: Designed Epigenetic MTSD and Small-molecule MTSD.- Anti-cancer Polypharmacology.- Cardiovascular Polypharmacology.- Neuronal Polypharmacology.- Pulmonary Polypharmacology.- Polypharmacology of Metabolic Disease.- Polypharmacology of Infectious Disease.- Polypharmacology of Inflammation.- Anti-psychotics Polypharmacology.- Anti-aging Polypharmacology.- Polypharmacology in Drug Repurposing.- Polypharmacology and Unintended Drug Promiscuity.- Polypharmacology Pharmacokinetics.- The Future of Polypharmacology.- PART II. Polypharmacology in New Drug Development: Strategies and Protocols.- Designed MTSD Discovery Process.- Designed MTSD Discovery Strategies.- Designed MTSD Discovery Technologies.- Designed MTSD Discovery Databases.- Designed MTSD Target Deconvolution.-Designed MTSD Target Validation.- Designed MTSD Lead Identification and Optimization.- Designed MTSD Discovery Protocols.- Natural Products in MTSD Discovery.- Polypharmacology Procedures for Drug Repurposing.- Polypharmacology Procedures for Drug Promiscuity Discovery.
Notă biografică
Zhiguo Wang PhD received his PhD in cardiovascular pharmacology from McGill University, Canada. He is presently the Director of the Division of Drug Discovery, Meditech Institute of Research and Advance (USA) and a Distinguished Professor in the Department of Pharmacology, Harbin Medical University. He is an author of over 150 research articles in prestigious scientific journals and of 6 monographs and 15 book chapters with renowned scientific publishers. His research interests cover cardiovascular disease and pharmacology, molecular pharmacology, epigenetic polypharmacology. His research group is one of the earliest investigators who proposed “one drug, multiple targets” polypharmacology concept and provided the experimental evidence in support of the epigenetic polypharmacology.
Textul de pe ultima copertă
There is a growing interest in unmet needs for the development of a new discipline in drug discovery and in university education on Polypharmacology. However, there has not been a book with the comprehensive compilation of basic knowledge and advanced methodology on Polypharmacology. This book aims to meet the needs of making Polypharmacology a new sub-discipline of Pharmacology, not only being a hot area of pharmacological research and education but also a new paradigm for drug discovery. It contains the contents covering the entire scope of Polypharmacology including systemic in-depth exposition of basic knowledge, novel concepts, innovative technologies, and translational and clinical applications by showcasing state-of-the-art strategies and step-by-step instructions of cutting-edge methods. The contents of Polypharmacology targets broad readerships including scientists in pharmacology research and drug development, and university teachers and graduates in medical school or schoolof pharmacy.
- Rich in illustrations and tables to showcase readers for better understanding the concepts and technologies related to Polypharmacology;
- Provides comprehensive, systemic, holistic, and explicit explanations and discussion of the fundamental knowledge, background information, conceptual evolution, and updated methodology, as well as in-depth mechanisms behind the knowledge and methodology of Polypharmacology;
- Main emphasis on rationally designed Polypharmacology or “multi-target, single-drug (MTD)” pharmacology, which represents the major future direction of Polypharmacology and Pharmacology;
- Describes the clinical applications of Polypharmacology to various human diseases in the clinical and preclinical settings;
- Contains a wide collection of the state-of-the-art Polypharmacology technologies applicable to the designed MTD discovery and the step-by-step descriptions of drug discovery process applying Polypharmacology principles and methodologies.
Caracteristici
Provides comprehensive, in-depth mechanisms behind the knowledge and methodology of Polypharmacology Emphasis on rationally designed Polypharmacology or “multi-target, single-drug (MTSD)” pharmacology Contains a wide collection of the state-of-the-art Polypharmacology technologies